Baxter Revenue and Competitors
Estimated Revenue & Valuation
- Baxter's estimated annual revenue is currently $12.4B per year.
- Baxter's estimated revenue per employee is $323,276
- Baxter's total funding is $1.7B.
- Baxter's current valuation is $42.9B. (January 2022)
Employee Data
- Baxter has 38512 Employees.
- Baxter grew their employee count by 1% last year.
Baxter's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Transformation Officer | Reveal Email/Phone |
2 | VP Human Resources R&D | Reveal Email/Phone |
3 | Head HR Operations & Services (Global HR Service Center) | Reveal Email/Phone |
4 | VP Business Services | Reveal Email/Phone |
5 | EVP Research and Development | Reveal Email/Phone |
6 | Norm Compliance Officer | Reveal Email/Phone |
7 | EVP - North America | Reveal Email/Phone |
8 | Head Product, New Medical Sensors | Reveal Email/Phone |
9 | Quality Control Officer | Reveal Email/Phone |
10 | Head U.S. Commercial & Medical IT and Global CRM Operations Rare Disease | Reveal Email/Phone |
Baxter Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12450M | 38512 | 1% | $1.7B | $42.9B |
#2 | $11.1M | 29 | -12% | N/A | N/A |
#3 | $31800M | 109578 | 4% | $367M | $146B |
#4 | $4180M | 14516 | 1% | $550M | $18.5B |
What Is Baxter?
Baxter International Inc. is a global medical products and services company that, through its subsidiaries, provides critical therapies for people with life-threatening conditions. Baxter's products and services in bioscience (biopharmaceuticals, vaccines, biosurgery and transfusion therapies), medication delivery and renal therapy are used by health-care providers and their patients in more than 100 countries.
keywords:N/A
$1.7B
Total Funding
38512
Number of Employees
$12.4B
Revenue (est)
1%
Employee Growth %
$42.9B
Valuation
N/A
Accelerator
Baxter News
Late to the party with a January offer, the Oklahoma Sooners missed the top 5 for 2023 four-star running back Cedric Baxter.
The Texas Longhorns are gaining momentum on the recruiting trail for the 2023 cycle. After two commitments on Saturday, the good news...
The Miami football program is in a good position with four-star 2023 running back Cedric Baxter after he named the Hurricanes one of his...
PDF DEERFIELD, Ill. - 2021-09-23 Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of premix Norepinephrine Bitartrate in 5% Dextrose Injection (norepin ...
PDF DEERFIELD, Ill. - Thu, 07/08/2021 - 12:00 Baxter International Inc. (NYSE:BAX), a leading global medical products company, today released its 2020 Corporate Responsibility Report. This year's report details final achievement towards Baxter's 2015-2020 set of corporate responsibility priori ...
Other Companies in Deerfield
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $28360M | 42664 | 8% | N/A |
#2 | $48410M | 69734 | 6% | N/A |
#3 | $33962.7M | 106868 | 5% | N/A |
#4 | $132510M | 126948 | 8% | $71.9M |